A systematic review and meta-analysis of investigating the mutual impact of COVID-19 and psoriasis: Focusing on COVID-19 course in psoriasis and the opinion on biologics in this setting.

Nazila Ghoreishi AminSepehr Khosravi Najmolsadat Atefi Farnoosh Seirafianpour Sahand FarhoodiAzadeh Goodarzi

Published in: Immunity, inflammation and disease (2023)

Studies have shown that biologic therapy for psoriasis did not increase the risk of hospitalization due to COVID-19 infection and may have even offered some protection. Treatment adherence was higher in psoriasis patients receiving biologic therapies than those receiving conventional therapies. These findings suggest that psoriasis treatment did not negatively impact COVID-19 infection and that treatment could be continued on a case-by-case basis during the pandemic.

Keyphrases

coronavirus disease
sars cov
rheumatoid arthritis
combination therapy
atopic dermatitis
metabolic syndrome